Interestingly, the upregulation of ITGB3 expression by reactive oxygen species (ROS) markedly promoted the migration and invasion capacities of CRC cells 21, and its antagonist significantly decreased metastasis burden and improved survival in CRC xenograft models 39. The gene discussed is ITGB3; the disease is colorectal carcinoma.